Blueprint Medicines
Hongliang Shi has been working at Blueprint Medicines since October 2015, where Hongliang currently holds the position of Director of Biostatistics. Prior to their current role, Hongliang worked at Takeda Pharmaceuticals as an Associate Director in Global Statistics.